Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Suppression Treatment”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Large-scale testing (Phase 3)UnknownNCT03664895
What this trial is testing

Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)

Who this might be right for
Breast Cancer Invasive
Seoul National University Hospital 224
Large-scale testing (Phase 3)Ended earlyNCT02532400
What this trial is testing

Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients

Who this might be right for
Breast Cancer
Ruijin Hospital 21
Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Not applicableLooking for participantsNCT06606535
What this trial is testing

ENDO-BRAIN: Effects of Endocrine Adjuvant Therapy with Aromatase Inhibitors on the Cognitive Function of Breast Cancer Patients

Who this might be right for
Cognitive Side Effects of Cancer TherapyHypoestrogenism
Ospedale Policlinico San Martino 60
Large-scale testing (Phase 3)Study completedNCT00066690
What this trial is testing

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

Who this might be right for
Estrogen Receptor Positive Breast CancerProgesterone Receptor Positive TumorRecurrent Breast Carcinoma+5 more
ETOP IBCSG Partners Foundation 3,066
Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Not applicableNot Yet RecruitingNCT07311122
What this trial is testing

Endocrine Therapy Base on 21-gene RS

Who this might be right for
Breast Cancer
Gangnam Severance Hospital 4,000
Not applicableStudy completedNCT00128726
What this trial is testing

The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function

Who this might be right for
Menstrual CycleHealthy
Milton S. Hershey Medical Center 62
Testing effectiveness (Phase 2)Study completedNCT02440230
What this trial is testing

Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients

Who this might be right for
Breast Cancer
Shanghai Jiao Tong University School of Medicine 110
Not applicableStudy completedNCT03571841
What this trial is testing

Sexual Health and Rehabilitation After Ovarian Suppression Treatment

Who this might be right for
Breast Cancer SurvivorsSexual Function DisturbancesOvarian Suppression Treatment
Dana-Farber Cancer Institute 20
Not applicableStudy completedNCT05122377
What this trial is testing

RWE About QOL and Compliance of Patients With OFS in China

Who this might be right for
Breast CancerQuality of LifeHormone Receptor-positive Breast Cancer
Fudan University 562
Testing effectiveness (Phase 2)Study completedNCT02550977
What this trial is testing

Russia/Ukraine Suppression of Ovarian Activity Study

Who this might be right for
Contraception
Bayer 91
Testing effectiveness (Phase 2)Ended earlyNCT00498901
What this trial is testing

Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
University of Washington 1
Large-scale testing (Phase 3)Study completedNCT00659373
What this trial is testing

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

Who this might be right for
Breast CancerFatigueSleep Disorders
ETOP IBCSG Partners Foundation 86
Testing effectiveness (Phase 2)Looking for participantsNCT05974449
What this trial is testing

Lactobacillus Vaginalis Capsules for Treatment of Vulvovaginal Atrophy in Young Breast Cancer Patients

Who this might be right for
Breast Cancer Female
The First Affiliated Hospital with Nanjing Medical University 60
Large-scale testing (Phase 3)Looking for participantsNCT05879926
What this trial is testing

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Who this might be right for
Breast Cancer
NRG Oncology 3,960
Not applicableLooking for participantsNCT06050109
What this trial is testing

The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

Who this might be right for
Breast Cancer FemaleEndocrine Therapy
Hongmei Zheng, PhD 1,200
Testing effectiveness (Phase 2)Study completedNCT03628066
What this trial is testing

Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 24
Large-scale testing (Phase 3)UnknownNCT03137368
What this trial is testing

Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）

Who this might be right for
CYP2D6 Polymorphism
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 300
Post-approval studies (Phase 4)Looking for participantsNCT05333328
What this trial is testing

OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk

Who this might be right for
Breast CancerEstrogen Receptor Positive TumorHER2-negative Breast Cancer+2 more
Gangnam Severance Hospital 418
Load More Results